Home / News (Page 5)

News

Invectys raises 1.7 million Euros more to finance the ...

Invectys raises 1.7 million Euros more to  finance the clinical development of its therapeutic cancer vaccine With a total of 10 million euros raised, new premises,…

Read more

Invectys Initiates Phase I Clinical Trial Evaluating IN...

Invectys Initiates Phase I Clinical Trial Evaluating INVAC-1 Therapeutic Vaccine for Cancer Patients A new clinical hope in cancer immunotherapy Paris, May 12th,…

Read more

Invectys receives ANSM approval to start clinical trial...

Invectys receives ANSM approval to start clinical trial for INVAC-1, its leading anticancer immunotherapy INVAC-1 is an anticancer candidate vaccine targeting…

Read more

Press Release – Invectys Initiates Phase I Clinical T...

A new clinical hope in cancer immunotherapy Paris, May 12th, 2015 – Invectys announces today that it has initiated a phase I clinical trial of its immunotherapeutic…

Read more

Invectys publications

First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G François Anna, Elodie Bole-Richard, Joel LeMaoult, Marie Escande, Martin Lecomte,…

Read more